MedTrace Logo

Identifying Novel Biomarkers in Early Rheumatology Patients

NCT03843658 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2019-02-18

No results posted yet for this study

Summary

Patients new to a rheumatology practice will be asked if they want to consent to their blood sample, medical records, and hand/foot x-rays (with sharp scores) for the analysis and correlation with the diagnosis they will receive from the rheumatologist.

Conditions

  • Rheumatologic Disorder

Interventions

OTHER

There is no intervention, but a diagnosis.

Cohorts will be determined by the primary rheumatology diagnosis.

Sponsors & Collaborators

  • Inova Diagnostics Inc

    collaborator UNKNOWN

  • Bristol-Myers Squibb

    collaborator INDUSTRY

  • University of Nebraska

    collaborator OTHER

  • Arthritis Northwest PLLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-15
Primary Completion
2020-03-15
Completion
2020-09-15

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03843658 on ClinicalTrials.gov